225 related articles for article (PubMed ID: 2944915)
21. Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS.
Madi N; Steiger G; Estreicher J; Schifferli JA
J Immunol; 1992 Feb; 148(3):723-8. PubMed ID: 1530955
[TBL] [Abstract][Full Text] [Related]
22. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
[TBL] [Abstract][Full Text] [Related]
23. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients.
Kanto T; Hayashi N; Takehara T; Katayama K; Kato M; Akiyama M; Kasahara A; Fusamoto H; Kamada T
J Med Virol; 1996 Oct; 50(2):126-34. PubMed ID: 8915878
[TBL] [Abstract][Full Text] [Related]
24. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
Ng YC; Schifferli JA; Walport MJ
Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
[TBL] [Abstract][Full Text] [Related]
25. Detection and characterization of circulating immune complexes in HIV-related diseases.
Carini C; D'Amelio R; Mezzaroma I; Aiuti F
Diagn Clin Immunol; 1987; 5(3):135-9. PubMed ID: 3480082
[TBL] [Abstract][Full Text] [Related]
26. Influence of processing by erythrocyte C3b/C4b receptors (CR1) on binding of immune complexes to Raji cells and polymorphonuclear granulocytes.
Rasmussen JM; Jepsen HH; Svehag SE
Scand J Immunol; 1987 Oct; 26(4):437-44. PubMed ID: 2961050
[TBL] [Abstract][Full Text] [Related]
27. A study of in vivo immune complex formation and clearance in man.
Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
[TBL] [Abstract][Full Text] [Related]
28. [Cytotoxicity induced by the serum of patients with AIDS and at high risk of AIDS against cells infected with Epstein-Barr virus].
De la Barrera S; Fejes M; Riera NE; Scaglione C; Pérez Blanco R; de Bracco MM
Rev Argent Microbiol; 1985; 17(3):137-43. PubMed ID: 2829276
[TBL] [Abstract][Full Text] [Related]
29. Leprosy: altered complement receptors in disseminated disease.
Tausk F; Hoffmann T; Schreiber R; Gigli I
J Invest Dermatol; 1985 Jul; 85(1 Suppl):58s-61s. PubMed ID: 3159807
[TBL] [Abstract][Full Text] [Related]
30. In vivo binding of circulating immune complexes by C3b receptors (CR1) of transfused erythrocytes.
Inada Y; Kamiyama M; Kanemitsu T; Ikegami H; Watanabe K; Clark WS; Asai Y
Ann Rheum Dis; 1989 Apr; 48(4):287-94. PubMed ID: 2523692
[TBL] [Abstract][Full Text] [Related]
31. Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE.
Thomsen BS; Nielsen H; Andersen V
Scand J Rheumatol; 1987; 16(5):339-46. PubMed ID: 2961056
[TBL] [Abstract][Full Text] [Related]
32. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
33. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
[TBL] [Abstract][Full Text] [Related]
34. Circulating IgA immune complexes in AIDS.
Lightfoote MM; Folks TM; Redfield R; Gold J; Sell KW
Immunol Invest; 1985 Aug; 14(4):341-5. PubMed ID: 3877683
[TBL] [Abstract][Full Text] [Related]
35. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
36. Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS Vaccine Clinical Trials Networks.
Montefiori DC; Graham BS; Zhou JY; Zhou JT; Ahearn JM
J Infect Dis; 1994 Aug; 170(2):429-32. PubMed ID: 8035031
[TBL] [Abstract][Full Text] [Related]
37. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
[TBL] [Abstract][Full Text] [Related]
38. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
Bobak DA; Frank MM; Tenner AJ
Eur J Immunol; 1988 Dec; 18(12):2001-7. PubMed ID: 2975599
[TBL] [Abstract][Full Text] [Related]
39. Complement activation is associated with the presence of specific human immunodeficiency virus (HIV)-anti-HIV immune complexes in patients with acquired immunodeficiency syndrome-related complex or lymphoadenopathy syndrome.
Carini C; Perricone R; Fratazzi C; Fontana L; De Carolis C; D'Amelio R; Sirianni MC; Aiuti F
Scand J Immunol; 1989 Sep; 30(3):347-53. PubMed ID: 2781247
[TBL] [Abstract][Full Text] [Related]
40. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
